Scott A Flanders
Overview
Explore the profile of Scott A Flanders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
3640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vaughn V, Krein S, Hersh A, Buckel W, White A, Horowitz J, et al.
Clin Infect Dis
. 2023 Dec;
78(6):1412-1424.
PMID: 38059532
Background: Despite antibiotic stewardship programs existing in most acute care hospitals, there continues to be variation in appropriate antibiotic use. While existing research examines individual prescriber behavior, contextual reasons for...
12.
Loser M, Horowitz J, England P, Esteitie R, Kaatz S, McLaughlin E, et al.
Crit Care Explor
. 2023 Nov;
5(11):e1004.
PMID: 37954901
Objectives: To identify opportunities for improving hospital-based sepsis care and to inform an ongoing statewide quality improvement initiative in Michigan. Design: Surveys on hospital sepsis processes, including a self-assessment of...
13.
Munroe E, Heath M, Eteer M, Gershengorn H, Horowitz J, Jones J, et al.
Chest
. 2023 Oct;
165(4):847-857.
PMID: 37898185
Background: Vasopressors traditionally are administered via central access, but newer data suggest that peripheral administration may be safe and may avoid delays and complications associated with central line placement. Research...
14.
Paje D, Heath M, Heung M, Horowitz J, Bernstein S, Flanders S, et al.
J Hosp Med
. 2023 Sep;
18(11):969-977.
PMID: 37771294
Background: Midline catheters (midlines) are increasingly used in patients with advanced chronic kidney disease (CKD). Objective: This study describes current practice and acute complications associated with midlines in CKD patients....
15.
Vaughn V, Gupta A, Petty L, Malani A, Osterholzer D, Patel P, et al.
JAMA Intern Med
. 2023 Jul;
183(9):933-941.
PMID: 37428491
Importance: Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic treatment, which increases antibiotic resistance and adverse events. Objective: To determine whether diagnostic stewardship (avoiding unnecessary urine cultures) or...
16.
Gershengorn H, Basu T, Horowitz J, McLaughlin E, Munroe E, OMalley M, et al.
Ann Am Thorac Soc
. 2023 May;
20(7):1003-1011.
PMID: 37166852
Little is known about the safety of infusing vasopressors through a midline catheter. To evaluate safety outcomes after vasopressor administration through a midline. We conducted a cohort study of adults...
17.
Vaughn V, Ratz D, McLaughlin E, Horowitz J, Flanders S, Middleton E, et al.
J Am Heart Assoc
. 2022 Sep;
11(19):e025914.
PMID: 36073649
Background A recent randomized trial, the MICHELLE trial, demonstrated improved posthospital outcomes with a 35-day course of prophylactic rivaroxaban for patients hospitalized with COVID-19 at high risk of venous thromboembolism....
18.
Govindan S, OMalley M, Flanders S, Chopra V
Am J Respir Crit Care Med
. 2022 Jul;
206(10):1286-1289.
PMID: 35862722
No abstract available.
19.
Delaney L, Bicket M, Hu H, OMalley M, McLaughlin E, Flanders S, et al.
J Hosp Med
. 2022 May;
17(7):539-544.
PMID: 35621024
Opioid and benzodiazepine prescribing after COVID-19 hospitalization is not well understood. We aimed to characterize opioid and benzodiazepine prescribing among naïve patients hospitalized for COVID and to identify the risk...
20.
Swaminathan L, Kaatz S, Chubb H, Tae K, Ramesh M, Fadel R, et al.
Infect Dis Ther
. 2022 Mar;
11(2):887-898.
PMID: 35267172
Introduction: While guidelines stronglyrecommend dexamethasone in critical COVID-19, the optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 remains unclear. Using data from a state-wide COVID-19 registry, we...